Stock Market News — September 15, 2026 — Morning Update — Last 12 Hours (Pacific Time)
Executive Summary
Markets are under broad pressure as the U.S. 10-year Treasury yield surged past 5% for the first time since 2007, battering equities across the U.S., Europe, and Asia ahead of an expected Federal Reserve rate hike on Wednesday. Bank of America's warning of weak Q3 investment banking revenue dragged financial stocks lower globally, while surging oil prices — amplified by U.S.-Iran tensions and a fresh Houthi attack — added another layer of macro stress. The single most important development: Goldman Sachs expects a 25bp Fed hike on September 16, and markets are repricing accordingly.
Sentiment Breakdown
| Sentiment | Count | Percentage |
|---|---|---|
| 🟢 Bullish | 52 | 25% |
| 🟡 Neutral | 28 | 13% |
| 🔴 Bearish | 130 | 62% |
Net Sentiment: Bearish — Rising yields, Fed hike expectations, BofA's revenue warning, and geopolitical escalation are overwhelming isolated pockets of strength in AI infrastructure and select upgrades.
Top Market-Moving Headlines
🔴 Macro / Rates | U.S. 10-year yield surges past 5%, highest since 2007
Market Impact: The yield spike is the session's gravitational force, pressuring rate-sensitive equities globally and accelerating defensive repositioning across asset classes.
🔴 Central Banks | Goldman Sachs expects 25bp Fed hike on Wednesday
Market Impact: With Goldman calling the hike and markets repricing, Wednesday's FOMC decision is the week's defining catalyst — any surprise hold or hawkish guidance could amplify volatility sharply.
🔴 Financials | Big U.S. bank shares fall after Bank of America Q3 investment banking outlook
Market Impact: BofA CEO flagged weak Q3 trading and dealmaking revenue, dragging major bank stocks lower and triggering a broad sell-off in Asian bank stocks overnight.
🔴 European Equities | European stocks fall to multi-month lows as Fed hike odds batter sentiment
Market Impact: The FTSE 100 fell 0.46%, CAC 40 dropped 0.34%, and DAX slipped 0.07% as rising U.S. yields and weak UK jobs data compounded regional pressure.
🔴 Crypto | Crypto stocks fall ahead of CLARITY Act vote and Fed decision
Market Impact: Bitcoin dropped roughly 2.9% to around $76,834, pulling Coinbase down 4.4% and Circle Internet down 4.7% in premarket as regulatory and rate uncertainty converged.
🟢 Luxury / France | L'Oréal overtakes LVMH as France's most valuable company
Market Impact: A notable milestone as luxury goods face China headwinds — Bernstein simultaneously cut its LVMH price target to €520 from €570, signaling the sector rotation is structural, not temporary.
🟢 Semiconductors | Skyworks Solutions surges 9.6%, Qorvo jumps 6.5% on M&A signals
Market Impact: Skyworks CEO publicly confirmed M&A interest at a conference, sparking a sympathy rally in Qorvo — the most significant chip-sector positive catalyst of the session.
🔴 Mortgage Insurance | MGIC Investment falls 4%, Radian Group drops 3.5% after FHFA director's PMI comments
Market Impact: FHFA Director Bill Pulte's comments on private mortgage insurance rattled the sector, with both stocks seeing sharp single-session declines.
🟢 AI / Tech | Meta launches subscription AI service "Meta One" and plans cost-saving AI chip deployment
Market Impact: Meta shares rose 2% on dual catalysts — a new revenue stream via subscription AI and Bloomberg-reported plans to deploy proprietary chips to reduce costs.
🟢 Pharma | Vera Therapeutics surges ~13-14% on positive TRUTAKNA trial results
Market Impact: One of the session's strongest biotech moves, driven by clean clinical data — a rare bright spot in an otherwise risk-off tape.
🔴 Retail | Boot Barn falls 6.5% on significant sales deceleration disclosure
Market Impact: The deceleration signal is a warning for discretionary retail broadly, particularly as consumer spending data remains mixed heading into the holiday season.
🟢 Pharma | Berenberg upgrades Eli Lilly to Buy with $1,400 price target, sees ~25% upside
Market Impact: A high-conviction upgrade on one of the market's most-watched names, with Lilly shares rising 1.6% in premarket on the call.
🔴 Strategy / Bitcoin | Strategy Inc. stock slides ~4.7% as Bitcoin tumbles
Market Impact: Strategy's leveraged Bitcoin exposure makes it a high-beta proxy for crypto sentiment — the slide reflects both BTC weakness and broader risk-off positioning.
🟢 IPO Pipeline | Intel-backed Altera files confidential S-1 with SEC for IPO
Market Impact: A significant chip-sector IPO signal — Altera's filing tests whether the market appetite for semiconductor listings holds despite the current yield-driven sell-off.
🔴 Wells Fargo | Wells Fargo cuts S&P 500 year-end target to 7,700 from 7,950, sees 5%-10% near-term downside
Market Impact: A notable target cut from a major bank, signaling institutional caution is hardening — though Wells Fargo simultaneously raised its loan growth outlook, reflecting internal tension in the macro view.
🟢 AI Infrastructure | Cognition partners with AWS to deploy Devin; Crusoe signs multi-year deal with Perplexity AI
Market Impact: Two enterprise AI infrastructure deals in one session underscore that hyperscaler and AI-native spending pipelines remain intact despite the Anthropic-driven AI slowdown scare.
🔴 Geopolitical / Energy | Gulf stock markets fall as Houthi attack escalates tensions; oil prices surge
Market Impact: Saudi Arabia's Tadawul fell 0.89% and oil's continued climb is feeding stagflation fears, complicating the Fed's path and pressuring equity multiples globally.
🟢 Semis / Analyst | Citi says SOX pullback looks like a buying opportunity; BofA raises U.S. semiconductor industry outlook to 18% annual CAGR
Market Impact: Two major banks pushing back against the AI chip sell-off narrative — Citi and BofA both argue the pullback is overdone, providing a potential floor for the sector.
🔴 Axon Enterprise | Axon Enterprise falls 5% on $1 billion convertible notes plan
Market Impact: Dilution concerns from the convertible offering outweighed any strategic rationale in the near term, a pattern repeated across several names this session.
🟢 Waystar | Waystar surges ~9% on potential sale reports
Market Impact: Healthcare payment software M&A speculation drove one of the session's sharpest premarket moves, with shares rising to $25.73 — a reminder that deal activity hasn't fully frozen despite rate pressure.
Tickers in Focus
| Ticker | Price / Change | Context |
|---|---|---|
| SKYW / SWKS | +9.6% | Skyworks CEO confirmed M&A interest; sympathy rally with Qorvo |
| QRVO | +6.5% | Rallied on Skyworks M&A confirmation |
| VERA | +13–14% | Positive TRUTAKNA clinical trial results |
| AXON | -5% | $1B convertible notes offering announced |
| BOOT | -6.5% | Disclosed significant sales deceleration |
| MSTR (Strategy) | -4.7% / $130.52 | Bitcoin tumble dragged leveraged BTC proxy lower |
| HOOD | -3.4% / $110.46 | Senate CLARITY Act procedural vote uncertainty |
| COIN | -4.4% | Bitcoin drop ~2.9% to ~$76,834 |
| CIFR / Circle | -4.7% | Crypto regulatory uncertainty ahead of CLARITY Act vote |
| META | +2% | Meta One subscription AI launch + cost-saving chip plans |
| LLY | +1.6% / $1,155.96 | Berenberg upgrade to Buy, $1,400 price target |
| BBIO | -6% | Put/call ratio ~7.94:1; heavy bearish options flow |
| CAVA | — | Put/call ratio 2.57x; bearish options dominance |
| PCAR | — | Institutional bearish diagonal put spread into October |
| WAY | +9.2% premarket / $25.73 | Potential sale reports |
| RCKT | -5.3% (after +8% initial pop) | FDA alignment initially bullish; rally faded |
| ETSY | +2.9–3.3% | Oppenheimer upgrade to Outperform, $90 price target |
| DELL | +5.1% | CFO comments drove recovery from Monday's ~5% decline |
| ARM | +3.7% | Partial recovery from prior session's sharp losses |
| AAPL | ~$329.61 | Testing breakout retest zone on 5-hour chart |
| NVDA | ~$212.50 | Testing key support with reversal signal |
| MSFT | — | High-tight flag near ATH, momentum fading |
| TSLA | $350–$370 | Stuck in chop range |
| GOOGL/GOOG | ~$346–$349 | Testing resistance levels |
| MU | ~$937 | Balancing on 200 SMA support |
| INTC | ~$99 | Battling 200 SMA and Fib resistance |
| WFC | — | Raised loan growth outlook; cut S&P 500 target to 7,700 |
| MTG | -4% | FHFA director PMI comments |
| RDN | -3.5% | FHFA director PMI comments |
| FWDI | -10% | Proposed SkyAI acquisition raised concerns |
| FEAM | -4.5% | $9.6M acquisition announced |
| PBF | +4.3% | Bounce after ~10% plunge on September 14 |
| SYY | -1.3% / $82.49 | $1B share offering priced; drew massive demand |
| QCOM | +3.9% | StoneX reiterated Buy, $270 price target |
| AZO | — | Options imply ~5.5% move on Sept. 22 earnings |
| FLEX | +2.6% | Spin-off name announced; Form 10 filed |
| ALMU | +7–7.4% | Sumitomo wafer production partnership |
| BLSM | +4.4% | Positive lung cancer trial data |
| MAAS | +3.4% | Subsidiary signed computing services deal |
| BBIO | -6% | Heavy bearish options flow |
| THC | -2.3% | Director sold $2.63M stake |
| RIG | — | Large bullish call spread targeting $7–$10 by Jan 2027 |
| EOG | — | Split sentiment options flow near 52-week high |
| ASML | — | Bullish long-dated call positioning despite near-term weakness |
| VRSN | — | Heavily one-sided call activity ahead of October expiration |
| UAL | -3.33% / $105.33 | Large bullish call spread placed despite stock down ~16% past month |
| NOK | +2.6% | Rosenblatt initiated Buy, $15 price target; bounce from -13% prior session |
Market Implications
The 10-year yield crossing 5% is not just a headline number — it's a valuation reset trigger. With Goldman calling a 25bp hike for Wednesday and Wells Fargo cutting its S&P 500 target to 7,700, the path of least resistance for equities is lower in the near term. Rate-sensitive sectors — REITs, high-multiple tech, and leveraged balance sheets — face the most acute pressure. The S&P 500 is reportedly trapped near 7,671 with overbought momentum indicators, while the Dow sits in a descending channel at 52,470, suggesting technical setups are aligned with the macro headwinds.
The AI narrative is bifurcating in real time. The Anthropic essay on slowing AI capability progress triggered a chip sell-off that analysts at Citi and BofA are now calling overdone — BofA raised its U.S. semiconductor industry CAGR outlook to 18%. Meanwhile, enterprise AI infrastructure deals (Cognition/AWS, Crusoe/Perplexity) and Meta's subscription AI launch signal that monetization is accelerating even as frontier model development faces scrutiny. Needham's identification of the next wave of AI infrastructure software beneficiaries suggests the smart money is rotating from hardware to software within the AI stack.
Geopolitical risk is back as a genuine market variable. The Houthi attack escalation, U.S.-Iran tensions lifting oil, and Amazon's inability to restore its Bahrain AWS facility due to war damage are no longer tail risks — they're affecting earnings, supply chains, and energy prices simultaneously. With European gas storage at just 67% capacity ahead of the heating season and Gulf markets selling off, the commodity-geopolitical complex is adding a stagflationary overlay to an already hawkish rate environment. Investors rotating toward energy (Stifel constructive on oil & gas, Keybanc raising E&P price targets) and away from rate-sensitive growth appears to be the dominant institutional trade.
Key Takeaways
- 10-Year Treasury at 5.03% — First time since 2007; this is the session's macro anchor and the primary driver of equity weakness globally.
- Goldman Sachs: 25bp hike Wednesday — The Fed decision is the week's most critical event; markets are positioned for the hike but guidance language could move markets sharply.
- Wells Fargo cuts S&P 500 target to 7,700 — Institutional caution hardening; near-term downside of 5–10% flagged explicitly.
- BofA Q3 investment banking warning — Weak trading and dealmaking revenue dragged U.S. and Asian bank stocks; watch for confirmation in upcoming earnings.
- SWKS +9.6%, QRVO +6.5% — CEO-confirmed M&A interest is the chip sector's biggest single-session catalyst; consolidation narrative is live.
- VERA +13–14% — Clean clinical data on TRUTAKNA; one of the session's strongest risk-reward biotech moves.
- Bitcoin ~$76,834, -2.9% — Crypto weakness ahead of CLARITY Act vote is pulling down the entire ecosystem of related stocks.
- META +2% — Dual catalysts (subscription AI + cost-saving chips) make Meta one of the few large-cap tech names with positive momentum today.
- L'Oréal overtakes LVMH — A structural signal on China luxury demand weakness; Bernstein's LVMH target cut to €520 reinforces the rotation.
- AXON -5% — $1B convertible notes offering is a dilution overhang; equity offerings in a rising-rate environment are being punished immediately.
- BOOT -6.5% — Sales deceleration disclosure is a warning flag for discretionary retail heading into the critical holiday setup period.
- Altera files confidential IPO S-1 — Intel-backed chip IPO tests market appetite; timing into a yield spike is a risk but signals confidence in the AI infrastructure demand story.
- Citi: SOX pullback is a buying opportunity — Contrarian call against the AI chip sell-off; BofA's 18% semiconductor CAGR upgrade adds institutional weight.
- Waystar +9.2% — M&A speculation in healthcare payments software; deal activity is not dead, just selective.
- European gas storage at 67% — Bernstein flagging five stocks to benefit from a tighter gas market; energy security trade is re-emerging in Europe.
- BofA Global Fund Manager Survey: cash at 3.9% — Rising cash levels signal investors are de-risking; historically a contrarian indicator but premature to call a bottom here.
- Cognition/AWS + Crusoe/Perplexity deals — Enterprise AI infrastructure spending pipeline remains intact despite frontier model slowdown fears.
- UAL options: large bullish call spread despite -16% past month — Someone is making a high-conviction bet on United Airlines recovery into Q3 earnings; worth watching.
- Crypto CLARITY Act vote — Senate procedural vote outcome could trigger 5–10% Bitcoin rally or extend the sell-off; binary risk event for crypto-adjacent equities.
- LLY +1.6% / Berenberg $1,400 target — Eli Lilly remains a consensus long with ~25% modeled upside; GLP-1 demand narrative intact despite broader market weakness.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/